3 ASX 200 shares to buy and hold for a decade

Investing in quality companies at attractive prices is crucial. Here are 3 ASX 200 shares I would buy and hold for a decade.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The potential of super-sized profits is very attractive for most people, which can lead to trading in the latest fad. However, one of the wealthiest people in the world, Warren Buffett, favours a different approach for building wealth on the share market – buying quality companies at attractive prices and holding for decades.

To use a Buffett-esque investing strategy, I think an investment in ASX 200 shares such as Wesfarmers Ltd (ASX: WES), Goodman Group (ASX: GMG) and Fisher & Paykel Healthcare Corp Ltd (ASX: FPH) could deliver investors with solid returns over the long term.

Wesfarmers 

Wesfarmers has continued to perform strongly amid the coronavirus pandemic, largely because of its popular Bunnings Warehouse and Officeworks chains. According to a recent update released on 9 June, Bunnings reported a surge in sales in in 2H20 (to date) of 19.2% and Officeworks saw sales grow by 27.8% for the same period. In addition, Catch.com.au, Wesfarmers' online marketplace, achieved strong sales growth of 68.7% for 2H20.

The increased demand during coronavirus restrictions is due to people spending more time with DIY projects, studying, working and general shopping from home. Fortunately, Wesfarmers appeared to hold the right businesses at the right time. However, the laggard in performance has been Target, with the company recently announcing the overhaul of its Target stores.

Due to the size of the business, its dominant position in the retail marketplace, I believe assigning Wesfarmers shares a spot in your portfolio could be rewarding over a decade.

Goodman Group

In a newsletter presented to investors on 11 June 2020, Goodman presented insights about the business, reaffirming that it remains in a solid position despite COVID-19 disruptions. The group's performance is supported by the demand for its infrastructure, which has accelerated because of the rise of online shopping amid the pandemic.

In addition, for the 9 months to 31 March 2020, the group reported occupancy rates of 97.5%, which highlights limited disruption in its warehouse facilities. Furthermore, Goodman Group's $4.8 billion in development work in progress demonstrates the demand for its properties. Future growth in development is expected.

The group is a major beneficiary of the increase in online shopping. By providing online retailers like Amazon with warehouses for stock, I believe Goodman Group should continue to see a lift in demand for its services over the long term.

Fisher & Paykel Healthcare 

Late last month, Fisher & Paykel delivered its preliminary final report to the ASX. In this announcement, the group revealed an increase in operating revenue of 18% to $1.26 billion. Additionally, it reported net profit after tax up 37% to $287.3 million.

While Fisher & Paykel has been a key beneficiary to the uplift in demand for healthcare products as a result of the coronavirus pandemic, it has also delivered increases in its earnings over the long term. Looking forward, I see the share benefitting from this continued demand for healthcare products because of an ageing population.

Foolish takeaway

Before buying shares, to analyse whether a share could represent a good long-term investment it's a good idea to ask whether you believe the company will still be thriving in a decade's time and try to anticipate if there will still be demand for its products or services. 

Take the 3 ASX 200 shares above, for example. People could continue to shop at Wesfarmers for their everyday items either in store and online. In addition, a greater number of the population could be shopping online, requiring more of Goodman's warehouses. Lastly, the rise in an ageing population could see continued demand for healthcare products produced by Fisher & Paykel. 

Motley Fool contributor Matthew Donald owns shares of Wesfarmers Limited. The Motley Fool Australia owns shares of Wesfarmers Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »